SCHEMBL2886829

SCHEMBL2886829

C=COC(=O)ON1C(=O)CCC1=O

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sulfur Dioxide SCHEMBL4557135 0.94
SCHEMBL12900561 0.82 MGLL (0.32) MGLL
SCHEMBL17447 0.80 MGLL (0.37) MGLL
SCHEMBL2973280 0.80 MGLL (0.31) MGLL
SCHEMBL2139612 0.76 MGLL (0.35) MGLL
SCHEMBL1111161 0.76 CYP3A4 (0.37)
SCHEMBL34300 0.75 MGLL (0.33) MGLL
SCHEMBL5570883 0.74 PARL (0.35) MGLL
SCHEMBL8402012 0.73 MGLL (0.32) MGLL
Ethylene Glycol SCHEMBL8522385 0.72 MGLL (0.33) MGLL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7745564-B2 System for synthesis of device forming monomers BAUSCH & LOMB INCORPORATED (US) 2010-06-29 US claimed
WO-2007002343-A2 NOVEL SYSTEM FOR SYNTHESIS OF DEVICE FORMING MONOMERS BAUSCH & LOMB INCORPORATED (US) 2007-01-04 WO claimed
US-20060293476-A1 Novel system for synthesis of device forming monomers PRECISION DERMATOLOGY, INC. 2006-12-28 US claimed
EP-0396364-A2 Novel vinyl carbonate and vinyl carbamate contact lens material monomers BAUSCH & LOMB INCORPORATED (US) 1990-11-07 EP claimed
WO-2013003318-A1 PROCESS FOR PREPARING VINYL CHLOROFORMATE BAUSCH & LOMB INCORPORATED (US) 2013-01-03 WO disclosed
US-8273914-B1 Process for preparing vinyl chloroformate BAUSCH & LOMB INCORPORATED (US) 2012-09-25 US disclosed
US-7745564-B2 System for synthesis of device forming monomers BAUSCH & LOMB INCORPORATED (US) 2010-06-29 US disclosed
US-7745564-B2 System for synthesis of device forming monomers BAUSCH & LOMB INCORPORATED (US) 2010-06-29 US disclosed
US-7745564-B2 System for synthesis of device forming monomers BAUSCH & LOMB INCORPORATED (US) 2010-06-29 US disclosed
US-7745564-B2 System for synthesis of device forming monomers BAUSCH & LOMB INCORPORATED (US) 2010-06-29 US disclosed
WO-2007002343-A3 NOVEL SYSTEM FOR SYNTHESIS OF DEVICE FORMING MONOMERS BAUSCH & LOMB (US) 2007-04-26 WO disclosed
WO-2007002343-A2 NOVEL SYSTEM FOR SYNTHESIS OF DEVICE FORMING MONOMERS BAUSCH & LOMB INCORPORATED (US) 2007-01-04 WO disclosed
US-20060293476-A1 Novel system for synthesis of device forming monomers PRECISION DERMATOLOGY, INC. 2006-12-28 US disclosed
US-6166236-A Vinyl carbonate and vinyl carbamate contact lens material monomers BAUSCH & LOMB INCORPORATED (US) 2000-12-26 US disclosed
EP-0757033-B1 Vinyl carbonate and vinyl carbamate monomers for a contact lens material BAUSCH & LOMB (US) 1999-03-03 EP disclosed
EP-0396364-B1 Copolymers of vinyl carbonate and vinyl carbamate as contact lens material BAUSCH & LOMB (US) 1997-06-11 EP disclosed
US-5610252-A Vinyl carbonate and vinyl carbamate contact lens material monomers BAUSCH & LOMB INCORPORATED (US) 1997-03-11 US disclosed
EP-0757033-A2 Vinyl carbonate and vinyl carbamate monomers for a contact lens material BAUSCH & LOMB INCORPORATED (US) 1997-02-05 EP disclosed
US-5070215-A Gas permeable contact lenses BAUSCH & LOMB INCORPORATED (US) 1991-12-03 US disclosed
EP-0396364-A2 Novel vinyl carbonate and vinyl carbamate contact lens material monomers BAUSCH & LOMB INCORPORATED (US) 1990-11-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060293476-A1 Novel system for synthesis of device forming monomers ILK, ALKBH3, FTO MGLL 2813/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.